Categories

Main Content

Top Content

Directory of Categories from the Journal and the latest article from it.

EditorialView Articles

Volume 23, Number 3Editorial

The Specialty Networks Localized to High-Risk Biochemically Recurrent Prostate Cancer Patient Playbook

Gautam JayramKatie GrantJayme NalleyNicole Smith

Prostate cancer (PCa) is the second-leading cause of cancer death among men in the United States. The American Cancer Society estimates that more than 299 010 men will be diagnosed with PCa in 2024, with more than 35 250 PCa-associated deaths.1 It is estimated that of those patients treated for localized PCa, 30% to 35% will experience biochemical recurrence (BCR), which further increases the risk of PCa death. Although multiple definitions have been proposed, BCR is generally present when a man has a persistently rising prostate-specific antigen (PSA) value after definitive local therapy (Table 1) in the absence of radiographic evidence of metastatic disease. This definition has evolved and will continue to develop, with advances in genomics, next-generation sequencing, and digital pathology.

ErratumView Articles
How Would You Manage?View Articles
IndexView Articles
Kidney CancerView Articles

Volume 23, Number 4Kidney Cancer

Imaging Techniques in the Diagnosis of Renal Cell Carcinoma: Contemporary Trends and Future Directions

Gautam Jayram

Increasing radiographic detection of incidental small renal masses has led to a growing concern regarding overtreatment of these lesions. Given the limitations of computed tomography and magnetic resonance imaging, there is an unmet need for improved kidney imaging techniques that can provide more accurate assessments of renal lesions. This review provides a summary of established kidney imaging modalities and also those likely to be meaningful in the near future. Kidney imaging has evolved, with several modalities contributing to the overall diagnostic landscape. There is great optimism that a new era of molecular imaging in renal cell carcinoma can vastly improve diagnostic capabilities and limit unnecessary invasive procedures.

Carcinoma, renal cellCarcinomaKidney neoplasmsmolecular imagingpositron-emission tomography

KOL InterviewView Articles
Literature ReviewsView Articles

Volume 23, Number 1Literature Reviews

Comparison of Methods for Ureteral Patency Visualization

Michelle BoytimMatthew J. JonesAlex S. BartPavel Svintozelskiy

The most common cause of ureteral trauma occurs during open, laparoscopic, or endoscopic procedures across multiple specialties. Ureteral injuries are often unrecognized or mismanaged. Early recognition of ureteral injuries by cystoscopy allows for prompt intervention. Visualization can be enhanced using agents that color or improve the contrast of ureteral flow.

Cystoscopydiagnostic imagingindigo carminemethylene bluefluorescein

LUGPA NewsView Articles
Meet The ExpertView Articles

Volume 23, Number 3Meet The Expert

Meet the Expert: Shelby Moneer, MS, CHES, from ZERO Prostate Cancer

Benjamin H. Lowentritt

Thank you for joining us today for our third “Meet the Expert” session with our special guest Shelby Moneer. Shelby is vice president of patient programs and education at ZERO Prostate Cancer. I’m your moderator for today, Benjamin Lowentritt. I’m the medical director of the prostate cancer program at Chesapeake Urology, and I am fortunate enough to be one of the medical advisors for ZERO, as well. Today’s “Meet the Expert” is sponsored by Cipla. For more information about Cipla, please visit their website at www.cipla.com.

Prostatic neoplasmspatient advocacy

Meeting ReviewsView Articles